SOLENO THERAPEUTICS INC short interest in 2022
In 2022, SOLENO THERAPEUTICS INC's disclosed short interest ran from 0.64% of shares outstanding on 14 Jan 2022 to 1.21% on 15 Dec 2022, a change of +0.57 percentage points. The year's high was 1.46% on 29 Jul 2022 and its low 0.28% on 13 May 2022, averaging 0.72% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.02 days on 15 Feb 2022. Full history: SOLENO THERAPEUTICS INC.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 0.64% (14 Jan 2022)
- End of year
- 1.21% (15 Dec 2022)
- Change
- +0.57 pp
- High
- 1.46% (29 Jul 2022)
- Low
- 0.28% (13 May 2022)
- Average
- 0.72%
- Highest days to cover
- 6.02 (15 Feb 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 0.64% | 2.13 | |
| 31 Jan 2022 | 0.64% | 1.91 | |
| 15 Feb 2022 | 0.71% | 6.02 | |
| 28 Feb 2022 | 0.70% | 4.11 | |
| 15 Mar 2022 | 0.63% | 2.17 | |
| 31 Mar 2022 | 0.75% | 1.00 | results (8-K), 10-K filed |
| 14 Apr 2022 | 0.47% | 1.00 | |
| 29 Apr 2022 | 0.35% | 1.00 | |
| 13 May 2022 | 0.28% | 1.00 | 10-Q filed, results (8-K) |
| 31 May 2022 | 0.38% | 1.00 | |
| 15 Jun 2022 | 0.43% | 1.00 | |
| 30 Jun 2022 | 1.03% | 1.00 | |
| 15 Jul 2022 | 0.89% | 1.00 | |
| 29 Jul 2022 | 1.46% | 1.00 | |
| 15 Aug 2022 | 0.66% | 1.00 | 10-Q filed, results (8-K) |
| 15 Nov 2022 | 0.64% | 1.11 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 1.06% | 1.00 | |
| 15 Dec 2022 | 1.21% | 2.25 |
See also: SOLENO THERAPEUTICS INC's full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.